1 / 2
google
Article details
- Package size
- 7
- Selling units
- 7
- Measure
- Durchstechflasche(n)
- Galenic form
- Augentropfen
- Galenic group
- Augenmittel
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.02 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.66 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Dompé International SA
1860 Aigle
Authorization information
- Swissmedic authorization number
- 67019
- Drug name
- Oxervate, collyre
- Galenic form
- AUL
- ATC Code
- S01XA24
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 06/09/2018
- Authorization expiration date
- 31/12/9999
- IT Number
- 11.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- OXERVATE gtt opht 7 pce
- Description (DE)
- OXERVATE Gtt Opht 7 Stk
- Market launch
- 06/09/2018
- Narcotic (BTM)
- No